Phillip Mertz
Director/Miembro de la Junta en ALPHA COGNITION INC. .
Fortuna: 621 632 $ al 30/04/2024
Cargos activos de Phillip Mertz
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ALPHA COGNITION INC. | Director/Miembro de la Junta | 22/03/2021 | - |
Historial de carrera de Phillip Mertz
Antiguos cargos conocidos de Phillip Mertz.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Alpha Cognition, Inc. /old/
 Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada. | Director/Miembro de la Junta | - | - |
Formación de Phillip Mertz.
| Harvard University | Undergraduate Degree |
Estadísticas
Internacional
| Canadá | 3 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 3 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ALPHA COGNITION INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Alpha Cognition, Inc. /old/
Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Phillip Mertz
- Experiencia
